Eris Pharmaceuticals has
announced a license agreement
with Swiss firm Applied Pharma
Research for the distribution of the
Halykoo baby health product range
in Australia and New Zealand.
The pact will see Eris enter the
paediatric market, with Halykoo
developed by APR to match specific
formulations with the unique ages
and stages of children’s growth
along with specially created
delivery systems - see halykoo.com.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Dec 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Dec 15
NEW data from the Australian Institute of Health and Welfare has revealed around 43% (or 8.5 million) of Australians aged 16-85 have experienced a mental disorder at some point in their lives.
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.